company / advisory board
   
The success of Vitateq as a research-driven enterprise rests to a great extent on the quality of its scientific advisors. We are proud to have the commitment of the following individuals for their experience, achievements, and public visibility they can lend to us.

Prof. Dr. Klaus Lindpaintner Chief Scientific Officer, Analytical Technologies, Thermo Fisher Scientific.

Klaus Lindpaintner graduated from the University of Innsbruck Medical School with a degree in Medicine and from Harvard University with a degree in Public Health. He pursued postgraduate training and specialization in Internal Medicine, Cardiology, and Genetics in the United States and Germany and holds board certifications for these specialties. He practiced cardiology and pursued research in the area of cardiovascular disease genetics, most recently as an Associate Professor of Medicine at Harvard Medical School in Boston, Massachusetts.
He joined Hofmann La-Roche, Basle in 1997 as Head of Preclinical Research in cardiovascular diseases. Since 1998, he has been VP of Research and Director of Roche Genetics in Europe , followed by a position as chief scientific officer and vice president of research and development at Strategic Diagnostics Inc. . He holds adjunct and honorary professorships at Harvard University in Boston, Humboldt University in Berlin, and University of London, and serves on the editorial board of several scientific journals.


Prof. Dr. Friedrich Lottspeich, Director Emeritus of the department for protein analysis at the MPI for Biochemistry in Martinsried.

Friedrich Lottspeich studied chemistry at the University of Vienna, Austria. In 1978 he completed his PhD with Pehr Edman at the Max-Planck-Institut for Biochemistry in Martinsried, Germany, on the primary structure of fibrinogen. He worked at this same institute until 1984, when he was appointed as the leader of the independent research group "Microsequencing" at the Genetics Center of the University of Munich.
After habilitations at the University of Munich and the University of Innsbruck he returned in 1990 to the Max-Planck-Institut for Biochemistry in Martinsried as leader of protein analysis. His research interests center on methodical and practical approaches for protein structure elucidation and proteome analysis. He is cofounder of Toplab, a service company active in the area of protein and DNA analytic technologies as well as in proteomics.


Prof. Dr. Gerd Utermann, Director Emeritus of the Department of Human Genetics, Medical University of Innsbruck

Gerd Utermann studied law and medicine at the universities of Marburg and Freiburg, Germany and received his medical degree from the University of Marburg, Germany. He continued most of his scientific and professional career in Marburg specializing on genetic disorders of lipoprotein metabolism. Since 1984 he heads the genetic examination and information center of the University of Innsbruck and since 1985 presides over the Institute for Medical Biology and Human Genetics of Innsbruck. His research interests center on the genetic analysis of complex diseases such as lipoprotein disorders and atherosclerosis. He serves in the editorial boards of numerous scientific journals and was president of the Austrian Society for Human Genetics, the Austrian Atherosclerosis Society, and the European Society for Human Genetics.


Prof. Dr. Ludwig Wildt, Chair in Reproductive Medicine and Endocrinology at the Medical University of Innsbruck

Dr. Wildt graduated in medicine from the Rheinische Friedrich-Wilhelms-University in Bonn, Germany. Following the completion of his training at the University Clinic in Bonn, he started his career as an MD in the German Army. He continued his training as a specialist in gynecology at the University of Bonn and graduated with excellence "summa cum laude," promoted by his mentor Dr. G. Leyendecker. Dr. Wildt received his postdoctoral fellowship at the University of Pittsburgh, Pennsylvania, U.S. He was then appointed assistant professor at the gynaecology department at the University of Bonn under Dr. D. Krebs, and later at the Gynaecology Clinic at University of Erlangen, Germany. Dr. Wildt made his habilitation for Obstetric and Gynaecology at the Friedrich-Alexander Medical University of Erlangen. In 1990, Dr. Wildt received a position as Associate Professor for Gynaecology, Endocrinology, and Reproductive Medicine from the University of Erlangen, Germany. Since May 2003, Dr. Wildt is Full Professor for Reproductive Medicine and Endocrinology at the University of Innsbruck in Austria. His research is focused in neuroendocrinology of reproduction, climacterium and post-menopause, ovarial regulations/mechanisms, tuba function, and mechanisms of implantation.